REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Seegene Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Seegene Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Seegene Co.,Ltd. is engaged in developing and manufacturing molecular diagnostic reagents. The company offers IVD reagents including respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis pathogen, and others. Seegene Co.,Ltd. also offers medical instruments for extraction, multiplex PCR, real-time PCR and auto-electrophoresis. The company is based in Seoul, with subsidiaries in USA, UAE, Canada and Germany. Seegene Co.,Ltd. was established in 2000 as Seegene, Inc.

Headquarters
Taewon Bldg, 65-5 Bangi-Dong, Songpa-Gu
Seoul; Seoul; Postal Code: 138-050

Contact Details: Purchase the Seegene Co.,Ltd. report to view the information.

Website: http://seegene.co.kr

Basic Information
Total Employees:
Purchase the Seegene Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Seegene Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Seegene Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Seegene Co.,Ltd. report to view the information.
Incorporation Date:
September 18, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
25.47%
Purchase this report to view the information.
7.55%
Purchase this report to view the information.
6.31%
Purchase this report to view the information.
4.31%
Purchase this report to view the information.
1.23%
Subsidiaries
(재)씨젠의료재단
(주)나노헬릭스
Amplibio-Seegene Diagnostics S A P I De C V
Company Performance
Financial values in the chart are available after Seegene Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.63%▲
Total operating revenue
19.84%▲
Operating profit (EBIT)
N/A
EBITDA
252.13%▲
Net Profit (Loss) for the Period
N/A
Total assets
-0.66%▼
Total equity
-1.56%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.82%▲
Quick Ratio
-0.05%▼
Cash Ratio
0.63%▲

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Bayer Korea Ltd.
 
Hugel, Inc.
NutriBiotech Co., Ltd.
 
Glaxo Smithkline Korea Co.,Ltd.
St Pharm Co., Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo